| Financial Year |
March 31 2023 |
| Monetary Funds |
3,649,596,018.73 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
306,443,789.99 |
| Accounts Receivable |
1,326,619,862.48 |
| Advances to Suppliers |
280,149,382.05 |
| Other Receivables |
111,179,350.93 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
26,158,508.39 |
| Dividend Receivable |
-- |
| Inventories |
1,342,112,511.35 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
151,861,134.62 |
| Total Current Assets |
7,172,568,726.85 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
4,635,462.74 |
| Investment Properties |
-- |
| Fixed Assetes |
2,926,781,253.67 |
| Under-construction Projects |
87,389,790.48 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
123,794,871.15 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
4,924,317.80 |
| Deferred Income Tax Assets |
141,424,964.57 |
| Other Non-Current Assets |
11,538,105.82 |
| Sub-Total of Non-Current Assets |
3,485,253,700.53 |
| Total Assets |
10,657,822,427.38 |
| Short-Term Loans |
409,615,548.30 |
| Trading Financial liabilities |
17,742,281.91 |
| Notes Payable |
2,505,132,462.49 |
| Accounts Payable |
2,083,683,268.39 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
37,563,710.26 |
| Taxes Payable |
11,349,771.95 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
125,107,192.70 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
229,220,644.82 |
| Other Current Liabilities |
317,106,699.80 |
| Sub-Total of Current Liabilities |
6,328,534,431.56 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
668,503,804.52 |
| Special Payable |
-- |
| Estimatied Liabilities |
559,538,459.19 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,305,071,640.38 |
| Total Liabilities |
7,633,606,071.94 |
| Paid-In Capital(Or Share Stock) |
1,192,859,268.00 |
| Capital Surplus |
1,548,337,486.30 |
| Surplus Reserve |
48,150,769.04 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-184,604,232.03 |
| Minority Stockholder's Interest |
419,981,754.76 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,604,234,600.68 |
| Owner's Equity（Stockholder's Equity） |
3,024,216,355.44 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
10,657,822,427.38 |
